Moreover, this reagent provides an opportunity to study effects of STING inactivation in immune‐competent RCC genetic murine models to further examine if STING inhibition could be explored as a treatment direction for RCC patients by balancing STING function in regulating both intrinsic cellular programs such as the one identified here and immune environment. The gene discussed is STING1; the disease is renal cell carcinoma.